GlassScriptPhysician profile
Robert J Piroli
NPI 1730180662
$3,685.50
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $1,886 · 2021: $560 · 2022: $400.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,973.56 | 2019-2022 | |
| Janssen Biotech, INC. | $305.58 | 2019-2022 | |
| Myovant Sciences INC. | $282.70 | 2021-2022 | |
| Boston Scientific Corporation | $281.48 | 2019-2020 | |
| Astellas Pharma US INC | $250.46 | 2019-2022 | |
| Blue Earth Diagnostics | $149.56 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $141.46 | 2020-2021 | |
| Dendreon Pharmaceuticals LLC | $96.55 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $62.67 | 2021-2022 | |
| Pfizer INC. | $53.50 | 2019-2022 | |
| Telix Pharmaceuticals | $25.79 | 2022 | |
| Palette Life Sciences, INC. | $21.36 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.25 | 2019 | |
| Amgen INC. | $12.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.08 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Piroli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.